key: cord-1048201-96hnzg34
authors: Tripathy, Sujit Kumar; Varghese, Paulson; Panigrahi, Sibasish; Panda, Bijnya Birajita; Srinivasan, Anand; Sen, Ramesh Kumar
title: Perioperative mortality and morbidity of hip fracture among COVID-19 infected and non-infected patients: A systematic review and meta-analysis
date: 2021-05-20
journal: Chin J Traumatol
DOI: 10.1016/j.cjtee.2021.05.004
sha: 28afc157de3be85d5ee4782e0c269f3b4d138634
doc_id: 1048201
cord_uid: 96hnzg34

PURPOSE: Hip fractures among elderly patients are surgical emergencies. During COVID-19 pandemic time, many such patients could not be operated at early time because of the limitation of the medical resources, the risk of infection and redirection of medical attention to a severe infective health problem. METHODS: A search of electronic databases (PubMed, Medline, CINAHL, EMBASE and the Cochrane Central Register of Controlled Trials) with keywords "COVID", "COVID-19", “SARS-COV-2”, “Corona”, "pandemic", "hip fracture", "trochanteric fracture" and "neck femur fracture" revealed 64 studies evaluating treatment of hip fracture in elderly patients during COVID-19 pandemic time. After screening, 7 studies were identified that described the mortality and morbidity in hip fractures in both COVID-19 infected (COVID-19 +) and non-infected (COVID-19 −) patients. The 30-day mortality rate, inpatient mortality rate, critical care/special care need, readmission rate and complications rate in both groups were evaluated. Data were analyzed using Review Manager (RevMan) V.5.3. RESULTS: There were significantly increased risks of 30-day mortality (32.23% COVID-19 + death vs. 8.85% COVID-19 − death) and inpatient mortality (29.33% vs. 2.62%) among COVID-19 + patients with odds ratio (OR) of 4.84 (95% CI: 3.13-7.47, p < 0.00001) and 15.12 (95% CI: 6.12-37.37, p < 0.00001), respectively. The COVID-19 + patients needed more critical care admission (OR = 5.34, 95% CI: 3.41-8.38, p < 0.00001) and they remain admitted for a longer time in the hospital (MD = 3.6, 95% CI: 1.74-5.45, p = 0.0001); but there was no difference in readmission rate between these 2 groups. The risks of overall complications (OR = 17.22), development of pneumonia (OR = 21.02), and acute respiratory distress syndrome/acute respiratory failure (OR = 32.96) was significantly high among COVID-19 + patients compared to COVID-19 − patients. CONCLUSIONS: There are increased risks of the 30-day mortality, inpatient mortality and critical care admission among hip fracture patients who are COVID-19 +. The chances of developing pneumonia and acute respiratory failure are more in these patients than in COVID-19 ‒ patients.

Conclusions: There are increased risks of the 30-day mortality, inpatient mortality and critical care admission among hip fracture patients who are COVID-19 +. The chances of developing pneumonia and acute respiratory failure are more in these patients than in COVID-19patients.

The COVID-19 has spread to more than 210 countries and affected 155,665,214 people worldwide, including 3,250,648 deaths as of 6th May 2021. 1 Because of the highly infectious nature of the disease and increased mortality rate among the elderly and immunocompromised patients, WHO has declared COVID-19 as a massive global pandemic and a significant public health problem. 1 In order to contain the spread of the disease and to accommodate such a vast patient pool of COVID-19, the healthcare resources were combined, and it was redirected to prioritize medical emergencies and COVID-19 treatment over non-emergency medical and surgical conditions. [2] [3] [4] [5] Hip fracture is a surgical emergency. Most of these patients are elderly individuals with numerous comorbidities. [6] [7] [8] [9] [10] They usually develop this fracture after a trivial fall at home because of poor bone quality and neurological disorders. Consequently, the incidence of hip fracture has remained stable even during the period of the COVID-19 pandemic. [11] [12] [13] Management of such fractures in these vulnerable immunocompromised patients is a big challenge. [11] [12] [13] There have been numerous advancements in the management of geriatric hip fracture, including better perioperative patient care, multidisciplinary approach, better implant, cementation procedures, fluid and antibiotic protocols and rehabilitation measures.

Despite that, 9%-13% of patients die within 30-day, and 14%-36% die within one year of hip fracture surgery. 14, 15 Besides, the functional outcome, quality of life, and return to preinjury activity level among the survivors are poor. 14, 15 Amidst the COVID-19 pandemic, when the J o u r n a l P r e -p r o o f entire medical attention is diverted towards COVID-19 management, delaying of hip fracture surgery might cause increased complication and perioperative mortality. Again, symptomatic infection with COVID-19 in the hip fracture patient might cause a delay in surgery, increased length of hospital stay, increased need for ventilator support, increased chances of respiratory complications and mortality. [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] A collaborative international study group reported 23.8% mortality among COVID-19 infected (COVID-19 +) patients (n = 1128) who underwent surgery. The mortality rate was even higher in emergency surgery (25.6%) and orthopaedic procedures (28.8%). 26 Many authors reported a higher 30-day mortality rate in hip fractures among COVID-19 + patients compared with COVID-19 non-infected (COVID-19 −) patients. [18] [19] [20] [21] [22] Nevertheless, few researchers did not observe a significant difference in mortality between these 2 groups of patients. 24 Several cohort studies reported no significant difference in time to surgery, type of treatment, complications, and 30-day mortality of hip fracture patients admitted during the COVID-19 pandemic when compared to the pre-pandemic period. 12, 19, 27, 28 Therefore, this systematic review and meta-analysis were conducted to evaluate the 30-day mortality and complications in COVID-19 + and COVID-19 − patients with hip fracture.

This systematic review/meta-analysis was performed following preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement standards (Fig. 1) . 29 It has been registered in PROSPERO. The registration number is CRD42020200592.

J o u r n a l P r e -p r o o f 

A literature search was performed on 25th July 2020 by 2 authors (PV, SP) to identify studies on hip fractures during COVID-19 pandemic. The electronic databases of PubMed, Medline, CINAHL, EMBASE and the Cochrane Central Register of Controlled Trials were searched using the keywords "COVID", "COVID-19", "SARS-COV-2", "Corona", "pandemic", "hip fracture", "trochanteric fracture" and "neck femur fracture". The search was limited to the English literature and human being. The title and abstract of retrieved articles were assessed carefully for possible inclusion in this review. The full text was assessed when J o u r n a l P r e -p r o o f the title and abstract were inconclusive. A manual search of the articles from the bibliography and book chapter were also performed to get more studies related to the topic. We resolved any discrepancies in study selection by a discussion between the authors. A third author (SKT) was consulted in the event of disagreement (Fig. 1) .

The inclusion criteria for this systematic review were as followed: (1) the study design must be a randomized-controlled trial or a cohort study; (2) The hip fracture in this review included both intracapsular (neck femur fracture) and extracapsular fracture (intertrochanteric and subtrochanteric fracture). Patients with clinical symptoms/signs of COVID-19 with positive nose or throat swab (assay with reverse transcriptase-polymerase chain reaction (RT-PCR)) for severe acute respiratory syndrome coronavirus-2 (SARS-COV-2) were classified as "COVID-19 +". Patients were classified as "COVID-19 −" if they were asymptomatic and the throat and nose swabs assays were negative for SARS-COV-2 using RT-PCR. Patients who were clinically symptomatic with a high grade of suspicion but the swab tests were negative, were labelled as "COVID-19

suspect". For quantitative analysis of data, all "COVID-19 suspect" patients were included in the COVID-19 + group and "COVID-19 not tested" patients were considered as COVID-19group.

J o u r n a l P r e -p r o o f Two authors (SKT, PV) extracted data from the included studies. The details (author,

year of publication, study design, demographic properties, surgical details, follow-up, 30-day mortality, the need of intensive care unit (ICU) care, readmission and complications) were filled up in standardized forms. Any disagreement was resolved through the discussion with a third author (RKS).

The primary objective of this study was 30-day mortality rate in both COVID-19 + and COVID-19 − patients. The secondary objectives were inpatient mortality rate, critical care/special care need (ICU/ high dependency unit (HDU)/ step down unit (SDU)), readmission rate and complications rate in both groups of patients.

The methodological quality and risk of bias of the studies were assessed by the Newcastle-Ottawa scale (NOS) by 2 authors (SKT and PV) ( Table 1) . 30 The NOS uses a star system with a maximum of 9 stars to evaluate a study in 3 domains (8 items): the selection of the study groups, the comparability of the groups, and the ascertainment of the outcome of interest. Each item was allocated 1 star for low risk and no star for high risk. Studies that received a score of 9 stars were considered as low risk of bias, 7 or 8 stars as moderate risk, and 6 or less as high risk of bias. 30 Any disagreements were resolved by discussion between 2 authors. If no agreement could be reached, the opinion of a third author (RKS) was sought.

J o u r n a l P r e -p r o o f 

Data were analyzed using Review Manager (RevMan) V.5.3. The data were pooled and expressed as mean difference (MD) with 95% confidence interval (CI) for continuous data.

The odds ratio (OR) and a 95% CI were evaluated for dichotomous outcomes. A p < 0.05 was considered as statistically significant. The heterogeneity among the cohort studies was assessed by Cochrane's Q (χ2, p<0.10) and quantified by I 2 . 31 I 2 > 50% and p < 0.10 were considered as a threshold of significant heterogeneity. [32] [33] [34] The random-effects model was applied to address the high degree of heterogeneity. [32] [33] [34] Results

Searches of electronic databases and other sources retrieved 64 studies, of which 7 studies were eligible for review after screening (Fig. 1) . 16 (Fig. 2) . Nevertheless, there was a significant difference between these 2 groups of patients in terms of the smoking habit.

There were significantly increased numbers of smokers (current and former) amongst the 

Surgical fixation or partial/total arthroplasty is a choice of treatment for hip fracture among elderly patients ( (Fig. 3) . Critical care admission, length of hospital stay, readmission and discharge to nursing home/rehab (Table 3) Four studies 18, 20, 24, 35 Fig 3) . Two studies (n = 185 patients) mentioned about the length of hospital stay. 18, 20 The COVID-19 + patients remained admitted for a significantly longer duration of time in hospital (MD = 3.6, 95% CI: 1.74-5.45, p = 0.0001). Kayani et al. 18 reported the meantime from surgery to hospital discharge, and it was significantly longer among COVOD + patients (13.8 + 4.6 days) compared to COVID-19 -(6.7 + 2.5 days) patients. The time from injury to surgery was not different between these 2 groups in that study (median time 3 days).

Regarding readmission or on-going admission within 30-day, there was no difference between COVID-19 + and COVID-19patients (MD = 1.16, 95% CI: 0.43-3.14, p = 0.76). 18, 20, 35 Three studies reported the number of patients discharged to nursing home/rehab/hospital. Fifty-five of 122 COVID-19 + patients were discharged to hospital/assisted care centre and 161/497 COVID-19patients were discharged to hospital/assisted care centre; this difference was clinically significant (OR = 1.75, 95% CI:

1.14-2.6, p = 0.01) (Fig. 4) .

J o u r n a l P r e -p r o o f 

For the 30-day mortality and inpatient mortality, there was no obvious publication bias as revealed from the symmetry of the funnel plot (Fig. 5) .

The main findings of this meta-analysis were increased inpatient mortality and 30-day mortality among hip fracture patients who were COVID-19 + compared to COVID-19 −. The odds of the need for critical care admission were 5.34 times higher in COVID-19 + patients. Presence of multiple comorbidities (>3 comorbidities) was associated with an increased risk of mortality among COVID-19 + patients. 18, 41 The report of COVID-19-Surg

Collaborative group on 30-day mortality in 1128 patients from 24 countries who underwent emergency and elective surgery during the early period of COVID-19 pandemic was appalling. 26 The overall 30-day mortality was 21.1% in the COVID-19 + group, and the majority of these COVID-19 + patients ended up with pulmonary complications (48.3%).

Deng et al. 42 reported that pre-existing comorbidities increased the risk of mortality from 41.5% to 72.5% among the COVID-19 + patients. Among the pre-existing comorbidities, diabetes mellitus, hypertension and cardiorespiratory diseases were associated with increased risk of complications. 43 We compared the comorbidity indices in both groups. The Charlson comorbidity index, clinical frailty scale and Nottingham hip fracture scores are validated measures of comorbidity and functional status in hip fracture patients. 24 These scores predict 30-day mortality and inpatient mortality in these patients. However, no significant differences in the comorbidity indices were observed between COVID-19 + and COVID-19patients.

This indicated that COVID-19 infection itself was an independent predictor of mortality in hip fracture patients. A significantly higher incidence of overall major complications, pneumonia and acute respiratory failure was observed in the COVID-19 + patients in the postoperative period. The study by Zhou et al. 44 reported 89% systemic complication among COVID-19 + surgical patients, including respiratory failure (54%), acute respiratory distress syndrome (31%), cardiac problems (23%) and acute kidney injury (15%). They hypothesized that surgical intervention augments the proinflammatory response, which has already been developed in a trauma victim because of the injury (second-hit phenomenon). 

This systematic review/meta-analysis has been registered in PROSPERO. The registration number is: CRD42020200592.

All the authors states that there is no conflict of interest.

WHO Coronavirus Disease (COVID-19) Dashboard. Data last updated: 2021/05/05, 4:43pm CEST

How we managed elective, urgent, and emergency orthopedic surgery during the COVID-19 pandemic

Personal protective equipment during the COVID-19 crisis: a snapshot and recommendations from the frontline of a university teaching hospital

Sustaining a national surgical training programme during the COVID-19 pandemic

COVID-19 and orthopaedic surgery: evolving strategies and early experience

Updated fracture incidence rates for the US version of FRAX

Impact of hip fracture on hospital care costs: a population-based study

Low Haemoglobin at Admission Is Associated With Mortality after Hip Fractures in Elderly Patients

The association between preoperative anemia and 30-day mortality and morbidity in noncardiac surgical patients

A Comprehensive Analysis of the Causes and Predictors of 30-Day Mortality Following Hip Fracture Surgery

Impact of the COVID-19 Pandemic on an Emergency Traumatology Service: Experience at a Tertiary Trauma Centre in Spain

Impact of the COVID-19 pandemic on orthopedic trauma workload in a London level 1 trauma center: the "golden month

Impact of the 2020 COVID-19 pandemic on the workload of the orthopaedic service in a busy UK district general hospital

Preoperative predictors for mortality following hip fracture surgery: a systematic review and meta-analysis

Mortality and cause of death in hip fracture patients aged 65 or older: a population-based study

Mortality rates of patients with proximal femoral fracture in a worldwide pandemic

Early outcomes after hip fracture surgery in COVID-19 patients in New York City

The effects of COVID-19 on perioperative morbidity and mortality in patients with hip fractures

30-day Mortality Rate of Patients with Hip Fractures during the COVID-19 Pandemic: A Single Centre Prospective Study in the United Kingdom

Increased Mortality and Major Complications in Hip Fracture Care During the COVID-19 Pandemic: A New York City Perspective

IMPACT-Scot report on COVID-19 and hip fractures

Modification of a Validated Risk Stratification Tool to Characterize Geriatric Hip Fracture Outcomes and Optimize Care in a Post COVID-19 World

Treatment of Proximal Femoral Fragility Fractures in Patients with COVID-19 During the SARS-CoV-2 Outbreak in Northern Italy

Evaluating the efficacy of a two-site ('COVID-19' and 'COVID-19-free') trauma and orthopaedic service for the management of hip fractures during the COVID-19 pandemic in the UK

Challenges and strategies in management of osteoporosis and fragility fracture care during COVID-19 pandemic

Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study

Are Hospitals Safe? A Prospective Study on SARS-CoV-2 Prevalence and Outcome on Surgical Fracture Patients. A Closer Look at Hip Fracture

Thirty-day mortality of patients with hip fracture during COVID-19 pandemic and pre-pandemic periods: A systematic review and meta-analysis

Reporting guidance considerations from a statistical perspective: overview of tools to enhance the rigour of reporting of randomized trials and systematic reviews

The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses

Measuring inconsistency in meta-analyses

Cochrane handbook for systematic reviews of interventions Version 5.0.0. The Cochrane Collaboration

How to interpret a meta-analysis and judge its value as a guide for clinical practice

Fixed-versus random-effects models in meta-analysis: model properties and an empirical comparison of differences in results

Hip Fracture Outcomes During the COVID-19 Pandemic: Early Results From New York

Does time from fracture to surgery affect mortality and intraoperative medical complications for hip fracture patients?

Surgery for a fracture of the hip within 24 hours of admission is independently associated with reduced short-term postoperative complications

Management of hip fractures during the COVID-19 pandemic at a high-volume hip fracture unit in the United Kingdom

Registro Nacional de Fracturas de Cadera. National Hip Fracture Registry annual report

Epidemiology, treatment and mortality of trochanteric and subtrochanteric hip fractures: data from the Swedish Fracture Register

Epidemiologic characteristics of traumatic fractures in elderly patients during the outbreak of coronavirus disease 2019 in China

Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 (COVID-19) in Wuhan, China: a retrospective study

Clinical Characteristics of Coronavirus Disease 2019 in China

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study